CN1456268A - Preparation of capsules against rhinitis - Google Patents

Preparation of capsules against rhinitis Download PDF

Info

Publication number
CN1456268A
CN1456268A CN 03118670 CN03118670A CN1456268A CN 1456268 A CN1456268 A CN 1456268A CN 03118670 CN03118670 CN 03118670 CN 03118670 A CN03118670 A CN 03118670A CN 1456268 A CN1456268 A CN 1456268A
Authority
CN
China
Prior art keywords
technology
volatile oil
relative density
beta
schardinger dextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 03118670
Other languages
Chinese (zh)
Inventor
毛友昌
毛晓敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 03118670 priority Critical patent/CN1456268A/en
Publication of CN1456268A publication Critical patent/CN1456268A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A process for preparing Chinese medicine "Biyanling capsule" for treating chronic nasosinusitis, rhinitis, nasal congestion, etc includes such steps as extracting from xanthium fruit by alcohol, decocting dregs, concentrating, drying, extracting volatile oil of magnolia flower and asarum herb, pulverizing 4 Chinese-medicinal materials including scutellaria root, mixing, granulating, adding menthol and additive, mixing all together, and loading in capsules. Its advantage is high curative effect and safety.

Description

The capsular preparation method of BIYANLING
Technical field
This invention relates to the processing technology technical field of Chinese patent medicine capsule, relates in particular to the capsular preparation method of BIYANLING.
Background technology
Capsule is a kind of pharmaceutical formulation commonly used, according to the relevant drug act of China, changes dosage form as a kind of new drug research, and the capsular original dosage form of BIYANLING is: the BIYANLING sheet.The BIYANLING sheet has been listed in second of the Drug Standard of Ministry of Public Health of the Peoples Republic of China " Chinese traditional patent formulation preparation ".The technology features of former dosage form is: Fructus Xanthii gets thick paste with 70% alcohol heating reflux, medicinal residues decoct with water clear paste; Flos Magnoliae, Herba Asari divide you can well imagine volatile oil; Four flavors such as Radix Scutellariae are ground into fine powder, with above-mentioned thick paste clear paste and right amount of auxiliary materials mixed pelletization, drying, add Mentholum, volatile oil mixing, and the tabletting sugar coating forms.This product contains volatile ingredient, easily loss in producing storage.Tablets, easy to carry, but tablet especially the disintegrate of coated tablet need the long time, affect the treatment, and sugar coating is more loaded down with trivial details.This product quality control standard is lower, does not set up quantitative target as yet.Have the shortcoming that influence quality based on former dosage form, we use the modern pharmaceutical technology this product technology are done necessary improvement, form new preparation, improve simultaneously and improve quality standard, guarantee the quality monitoring of product, and the raising curative effect is benefited the common people.
Summary of the invention
The purpose of this invention is to provide the capsular preparation method of a kind of BIYANLING, improve the quality of products and curative effect, satisfy needs of medical treatment better.
The objective of the invention is such realization:
The capsular preparation method of BIYANLING comprises the steps:
One, the capsular prescription of BIYANLING is formed
Fructus Xanthii (parching to brown) 100-300g Flos Magnoliae 75-225g Radix Angelicae Dahuricae 10-50g
Herba Asari 10-50g Radix Scutellariae 10-50g Bulbus Fritillariae Cirrhosae 20-60g
Semen Sojae Preparatum 20-60g Mentholum 1.5-5.0g
Right amount of auxiliary materials is made 1000 altogether.
Its optimum formula is:
Fructus Xanthii (parching to brown) 200g Flos Magnoliae 150g Radix Angelicae Dahuricae 30g Herba Asari 30g
Radix Scutellariae 30g Bulbus Fritillariae Cirrhosae 40g Semen Sojae Preparatum 40g Mentholum 3.2g
Right amount of auxiliary materials is made 1000 altogether.
Two, BIYANLING capsules preparation technique
Technology one is except that Mentholum, and all the other seven flavor medicines clean respectively, remove impurity, and it is standby to be up to the standards.Get Fructus Xanthii and be ground into coarse powder, extract 1-3 time with the 50-85% alcohol heating reflux, the backflow filtration is behind the filtrate recycling ethanol and to be condensed into thick paste standby; Medicinal residues decoct with water 1-2 time, and decocting liquid filters, and filtrate is condensed into the clear paste that relative density is 1.10-1.30 (90 ℃), and is standby.Flos Magnoliae, Herba Asari divide you can well imagine volatile oil, and above-mentioned volatile oil adds an amount of cyclodextrin and makes the cyclodextrin of volatile oil clathrate or become volatile oil ethanol liquid standby with an amount of dissolve with ethanol; Radix Scutellariae, Bulbus Fritillariae Cirrhosae, the Radix Angelicae Dahuricae, Semen Sojae Preparatum are ground into fine powder and above-mentioned thick paste, clear liquid and an amount of mixing of auxilliary grain, granulate, and drying is put coldly, adds Mentholum, cyclodextrin of volatile oil clathrate or alcoholic solution and appropriate amount of auxiliary materials mixing, and is encapsulated, quality inspection, and packing, promptly.
Technology two is except that Mentholum, and all the other seven flavors clean respectively, remove impurity, and it is standby to be up to the standards.Get Fructus Xanthii and be ground into coarse powder, extract 1-3 time with the 50-85% alcohol heating reflux, backflow filters, and merging filtrate is standby behind the recovery ethanol; Medicinal residues decoct with water 1-2 time, decocting liquid filters, alcohol extract behind filtrate and the above-mentioned recovery ethanol merges, being concentrated into relative density is 1.05-1.20 (60 ℃), best relative density is the concentrated solution of 1.08 (60 ℃), spray drying, collection dried cream powder/concentrate, drying gets dry extract, and it is standby to be ground into dried cream powder.Flos Magnoliae, Herba Asari divide that to you can well imagine volatile oil standby; Above-mentioned volatile oil adds an amount of cyclodextrin and makes the cyclodextrin of volatile oil clathrate or become volatile oil ethanol liquid standby with an amount of dissolve with ethanol; Radix Scutellariae, Bulbus Fritillariae Cirrhosae, the Radix Angelicae Dahuricae, Semen Sojae Preparatum are ground into fine powder and above-mentioned dried cream powder, cyclodextrin of volatile oil clathrate or volatile oil alcoholic solution and Mentholum and appropriate amount of auxiliary materials, and mixing, encapsulated, quality inspection, packing, promptly.
Three, make by technology one, two and be capsule.
Fructus Xanthii was ground into 5-30 purpose coarse powder in the technology, preferably was ground into 10 purpose coarse powder.
Any or the multiple mixing that adds adjuvant in the technology and can be in beta-schardinger dextrin-, hydroxyl beta-schardinger dextrin-, micropowder silica gel, starch, the dextrin light magnesium oxide etc. is used.
The relative density of concentrated solution is 1.05-1.20 (60 ℃) in the technology, and the spray drying inlet temperature is 100-200 ℃, leaving air temp 50-150 ℃; Best relative density is 1.08 (60 ℃), and inlet temperature is 150 ℃, and leaving air temp is 100 ℃.
The decocting condition of boiling is in the technology: amount of water is doubly measured for the 6-12 of dose for the first time, doubly measures for the 4-10 of dose for the second time; Decoct each 1-3 hour 1-3 time; The best is: 8 times of amounts of amount of water decocted 2.5 hours.
The condition of reflux is in the technology: the ethanol with 50-85% is solvent, adds the solvent that 3-15 doubly measures, backflow 1-2 time, each 1-5 time; The best is: with 70% ethanol is solvent, adds 6 times of amount solvents, reflux 2 times, and each 2 hours, or add 10 times of amount solvent refluxings 5 hours.
The relative density that is condensed into thick paste in the technology is 1.10-1.40 (80 ℃), and best relative density is 1.21 (80 ℃).
The relative density of clear liquid is 1.10-1.30 (90 ℃) in the technology, and best relative density is 1.20 (90 ℃).
The dry drying under reduced pressure that adopts in the technology, temperature is 50-80 ℃, the best is 60 ℃.
Cyclodextrin of volatile oil clathrate preparation in the technology: cyclodextrin can adopt a kind of in beta-schardinger dextrin-, the hydroxyl beta-schardinger dextrin-, the ratio of volatile oil and beta-schardinger dextrin-is: 1: 5-15 (ml/g), optimal proportion is: 1: 9 (ml/g), the ratio of volatile oil and hydroxyl beta-schardinger dextrin-is: 1: 3-10 (ml/g), optimal proportion is: 1: 6 (ml/g).
Flos Magnoliae, Herba Asari extract volatile oil and can adopt water steaming method or super critical extraction in the technology.
This invention its superiority compared with the prior art is: production technology more becomes to improving rationally, and quality standard increases on the original basis, makes the quality of product and curative effect that guarantee arranged.This product quality standard is improved comprehensively, and former dosage form standard has a microscopical identification and a physicochemical identification on differentiating, existing having increased differentiated the thin layer of Bulbus Fritillariae Cirrhosae, the Radix Angelicae Dahuricae, Radix Scutellariae; Increased heavy metal limit and must not cross 10/1000000ths on checking, arsenic salt must not cross 2/1000000ths; On assay, former dosage form does not have quantitative target, now Bulbus Fritillariae Cirrhosae has been carried out quantitatively.
The specific embodiment
The optimum implementation of this invention is: except that Mentholum, all the other seven flavors clean respectively, remove impurity, and it is standby to be up to the standards.Get Fructus Xanthii and be ground into coarse powder, extract 1-3 time with the 50-85% alcohol heating reflux, backflow filters, and merging filtrate is standby behind the recovery ethanol; Medicinal residues decoct with water 1-2 time, decocting liquid filters, alcohol extract behind filtrate and the above-mentioned recovery ethanol merges, being concentrated into relative density is 1.05-1.20 (60 ℃), best relative density is the concentrated solution of 1.08 (60 ℃), spray drying, collection dried cream powder/concentrate, drying gets dry extract, and it is standby to be ground into dried cream powder.Flos Magnoliae, Herba Asari divide that to you can well imagine volatile oil standby; Above-mentioned volatile oil adds an amount of cyclodextrin and makes the cyclodextrin of volatile oil clathrate or become volatile oil ethanol liquid standby with an amount of dissolve with ethanol; Radix Scutellariae, Bulbus Fritillariae Cirrhosae, the Radix Angelicae Dahuricae, Semen Sojae Preparatum are ground into fine powder and above-mentioned dried cream powder, cyclodextrin of volatile oil clathrate or volatile oil alcoholic solution and Mentholum and appropriate amount of auxiliary materials, and mixing, encapsulated, quality inspection, packing, promptly.

Claims (2)

1, the capsular preparation method of a kind of BIYANLING is characterized in that it may further comprise the steps:
(1) Fructus Xanthii was ground into 5-30 purpose coarse powder in the technology, preferably was ground into 10 purpose coarse powder, was condensed into thick paste, medicinal residues water steaming and decocting again after extracting with alcohol heating reflux.
(2) condition of reflux is in the technology: the ethanol with 50-85% is solvent, adds the solvent that 3-15 doubly measures, backflow 1-2 time, each 1-5 time, the best is: with 70% ethanol is solvent, adds 6 times of amount solvents, reflux 2 times, each 2 hours, or add 10 times of amount solvent refluxings 5 hours.
(3) the decocting condition of boiling is in the technology: amount of water is doubly measured for the 6-12 of dose for the first time, doubly measures for the 4-10 of dose for the second time; Decoct 1-3 time, each 1-3 hour, the best was: 8 times of amounts of amount of water, decocted 2.5 hours, and be condensed into clear paste/concentrated solution.
(4) relative density of concentrated solution is 1.05-1.20 (60 ℃) in the technology, and the spray drying inlet temperature is 100-200 ℃, and leaving air temp 50-150 ℃, best relative density is 1.08 (60 ℃), and inlet temperature is 150 ℃, and leaving air temp is 100 ℃.
(5) relative density that is condensed into thick paste in the technology is 1.10-1.40 (80 ℃), and best relative density is 1.21 (80 ℃).
(6) relative density of clear liquid is 1.10-1.30 (90 ℃) in the technology, and best relative density is 1.20 (90 ℃).
(7) Flos Magnoliae, Herba Asari extract volatile oil and can adopt water steaming method or super critical extraction method in the technology.
(8) the dry drying under reduced pressure that adopts in the technology, temperature is 50-80 ℃, the best is 60 ℃.
(9) adding adjuvant in the technology can be that any/multiple mixing in beta-schardinger dextrin-, hydroxyl beta-schardinger dextrin-, micropowder silica gel, starch, the dextrin light magnesium oxide etc. is used.
(10) cyclodextrin of volatile oil clathrate preparation in the technology: cyclodextrin can adopt a kind of in beta-schardinger dextrin-, the hydroxyl beta-schardinger dextrin-, the ratio of volatile oil and beta-schardinger dextrin-is: 1: 5-15 (ml/g), optimal proportion is: 1: 9 (ml/g), the ratio of volatile oil and hydroxyl beta-schardinger dextrin-is: 1: 3-10 (ml/g), optimal proportion is: 1: 6 (ml/g).
(11) with the standby composition of (1), (2), (3), (4), (5), (6), (7), (8), (9), (10) by the mixing, encapsulated that feeds intake of national standard prescription consumption standard, the BIYANLING capsule is made in quality inspection.
2, the capsular preparation method of BIYANLING according to claim 1, it is characterized in that the thin layer to Bulbus Fritillariae Cirrhosae, the Radix Angelicae Dahuricae, Radix Scutellariae is differentiated on quality control standard, must not cross 10/1000000ths to heavy metal limit, arsenic salt must not be crossed 2/1000000ths and detect, on assay, former dosage form does not have quantitative target, now Bulbus Fritillariae Cirrhosae has been carried out quantitatively.
CN 03118670 2003-02-21 2003-02-21 Preparation of capsules against rhinitis Pending CN1456268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 03118670 CN1456268A (en) 2003-02-21 2003-02-21 Preparation of capsules against rhinitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 03118670 CN1456268A (en) 2003-02-21 2003-02-21 Preparation of capsules against rhinitis

Publications (1)

Publication Number Publication Date
CN1456268A true CN1456268A (en) 2003-11-19

Family

ID=29411372

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 03118670 Pending CN1456268A (en) 2003-02-21 2003-02-21 Preparation of capsules against rhinitis

Country Status (1)

Country Link
CN (1) CN1456268A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2014333A1 (en) 2007-07-12 2009-01-14 Hakiman Shargh Research Company Use of cooling agents for treatment or prevention of lacrimation or eye burning
CN100464760C (en) * 2005-03-28 2009-03-04 中国人民解放军第二军医大学 Use of cocklebur fruit total glucoside extract in preparing anti inflammation reaction product
CN102397453A (en) * 2011-11-26 2012-04-04 苏州派腾生物医药科技有限公司 Method for preparing tablets for treating rhinitis
CN104127496A (en) * 2014-07-22 2014-11-05 韩峥华 Rhinitis and nasosinusitis treatment medicine
CN107456522A (en) * 2017-08-11 2017-12-12 河南龙都药业有限公司 A kind of Chinese medicine for treating rhinitis tablet and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100464760C (en) * 2005-03-28 2009-03-04 中国人民解放军第二军医大学 Use of cocklebur fruit total glucoside extract in preparing anti inflammation reaction product
EP2014333A1 (en) 2007-07-12 2009-01-14 Hakiman Shargh Research Company Use of cooling agents for treatment or prevention of lacrimation or eye burning
CN102397453A (en) * 2011-11-26 2012-04-04 苏州派腾生物医药科技有限公司 Method for preparing tablets for treating rhinitis
CN102397453B (en) * 2011-11-26 2013-08-21 苏州派腾生物医药科技有限公司 Method for preparing tablets for treating rhinitis
CN104127496A (en) * 2014-07-22 2014-11-05 韩峥华 Rhinitis and nasosinusitis treatment medicine
CN107456522A (en) * 2017-08-11 2017-12-12 河南龙都药业有限公司 A kind of Chinese medicine for treating rhinitis tablet and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1456268A (en) Preparation of capsules against rhinitis
CN1456256A (en) Compound pseudo-ginseng preparing method
CN1456223A (en) Preparation of gastrodia tuber Toufengling pills
CN1456289A (en) Preparing method gynaecologic capsule for regulating menstruation
CN1456284A (en) Preparation of ginseng and schisandra fruit capsules
CN1456236A (en) Preparation of woman effervescent tablets
CN1552364A (en) Xuefu ecchymosis eliminating pills and their preparation
CN1456250A (en) Antilipemic capsule preparing method
CN1456230A (en) Preparation of six component rehmannia root pills
CN1456231A (en) Preparation of cold and numbness eliminating pills
CN1548120A (en) Pain-relieving and abdominal mass-eliminatnig bolus and its prepn
CN1456260A (en) Rheumatic strychnos nux-vomica preparing method
CN1456248A (en) Preparing method for nourishing blood and tranquilization tablet
CN1456237A (en) Preparation of instant woman medicine
CN1456242A (en) Preparation of enhanced Chinese angelica root and astragalus root capsules
CN1552373A (en) Pills for preventing osteoproliferation and preparing method thereof
CN1456238A (en) Sedative tablet preparing method
CN1456249A (en) Preparation of sweet dream tablets
CN1552365A (en) Migraine treating pills and their preparation
CN1456296A (en) Tablets for improving vision acuity and nourishing kidney and preparation thereof
CN1537598A (en) Traditional Chinese medicine Conghuang bushen granule for tonifying kidney, and its prepn. method
CN1456283A (en) Preparing method of antilipemic capsule for invigorating pulse-beat
CN1456301A (en) Acadthopanax tablets for climacteric and preapration thereof
CN1552384A (en) Yilingjing pills and their preparation
CN1456267A (en) Preparation of tablets against irregular manstruation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication